香港科技探索(01137.HK)4月香港電子商貿業務合計平均每日訂單總商品交易額按月輕微下跌2.3%
格隆匯5月10日丨香港科技探索(01137.HK)公吿,與2024年2月情況相類似,2024年4月的業務及營運表現受到復活節及清明節長假期的影響,因此,香港電子商貿業務的合計平均每日訂單總商品交易額按月輕微下跌2.3%,達2160萬港元。然而儘管面對挑戰,公司仍能維持穩定的獨立客户數目於約594,000名(2024年3月:約609,000名)。此外,公司的每月活躍應用程式使用者達到約1,630,000名(2024年3月:約1,650,000名),展示公司的流動應用程式參與度及使用率均維持穩定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.